Details of issuance or disposal
Exercise status of warrants with exercise price adjustment clauses (monthly report)
2,700,000 new shares
5.40% (approximate calculation: 2,700,000 shares delivered during the month under review ÷ 49,938,119 shares outstanding at the end of the previous month)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of warrants with exercise price adjustment clauses (monthly report) |
| Number of shares to be issued or disposed of | 2,700,000 new shares |
| Dilution Rate | 5.40% (approximate calculation: 2,700,000 shares delivered during the month under review ÷ 49,938,119 shares outstanding at the end of the previous month) |
| Total number of issued shares | 49,938,119 shares (as of the end of the previous month) → Not disclosed |
| Exercise price | ¥46.0 (exercise price during the month under review; details and floor of the adjustment provisions: not disclosed) |
| Number of Stock Acquisition Rights | Total issue of 260,800 rights (27,000 exercised; 150,800 unexercised) |
| Procedures under the Corporate Code of Conduct | To demonstrate compliance with the exercise restrictions, the number of shares delivered across all series, the number of listed shares as of the payment date for the issue, and the exercise ratio subject to the exercise restrictions are stated (exercise ratio: 6.48%). |
| Most recent equity financing | 6 July 2026: Issue of Series 20 stock acquisition rights with an exercise price adjustment provision (issue price and amount: not disclosed) |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the Series 20 stock acquisition rights in September 2026.